// App-Quantinova.ai

FRI-703 : Oral Hypoglycemic Agents Give Better Glycemic Control in Saudi Type 2 Diabetic Patients Than Insulin Therapy

Researchers

Presenter

  • Suhad Bahijri

Principal Investigators

  • N/A

Medical Centers

  • King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia

  • Natl Public Hlth Inst, Helsinki, Finland

  • Faculty of Medicine- King Abdulaziz University, London, Canada

  • King Abdulaziz University,

  • King Saud Bin Abdulaziz for Health Sciences University, , Saudi Arabia

  • Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

  • Faculty of Medicine-King Abdulaziz University,

Locations

  • Finland

  • Canada

  • Saudi Arabia

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Diabetic retinopathy

  • Diabetes

  • Type 2 diabetes mellitus

  • Hyperglycemia

Biomarkers

  • Hemoglobin A1c

  • Insulin

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim